Division of Cardiac Surgery, Department of Surgery, and Center for Quality and Safety, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Department of Surgery, Keck School of Medicine of USC, University of Southern California, Los Angeles, California; Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Ann Thorac Surg. 2022 Jun;113(6):1954-1961. doi: 10.1016/j.athoracsur.2021.06.036. Epub 2021 Jul 17.
The Society of Thoracic Surgeons (STS) original coronary artery bypass graft surgery (CABG) composite measure uses a 1-year analytic cohort and 98% credible intervals (CrI) to classify better than expected (3-star) performance or worse than expected (1-star) performance. As CABG volumes per STS participant (eg, hospital or practice group) have decreased, it has become more challenging to classify performance categories using this approach, especially for lower volume programs, and alternative approaches have been explored.
Among 990 STS Adult Cardiac Surgery Database participants, performance classifications for the CABG composite were studied using various analytic cohorts: 1 year (current approach, 2017); 3 years (2015 to 2017); last 450 cases within 3 years; and most recent year (2017) plus additional cases to 450 total. We also compared 98% CrI with 95% CrI (used in other STS composite measures).
Using 3 years of data and 95% CrIs, 113 of 990 participants (11.4%) were classified 1-star and 198 (20%) 3-star. Compared with 1-year analytic cohorts and 98% CrI, the absolute and relative increases in the proportion of 3-star participants were 14 percentage points and 233% (n = 198 [20%] vs n = 59 [6%]). Corresponding changes for 1-star participants were 6.5 percentage points and 133% (n = 113 [11.4%] vs n = 48 [4.9%]). These changes were particularly notable among lower volume (fewer than 199 CABG per year) participants. Measure reliability with the 3-year, 95% CrI modification is 0.78.
Compared with current STS CABG composite methodology, a 3-year analytic cohort and 95% CrI increases the number and proportion of better or worse than expected outliers, especially among lower-volume Adult Cardiac Surgery Database participants. This revised methodology is also now consistent with other STS procedure composites.
胸外科医师学会(STS)最初的冠状动脉旁路移植手术(CABG)综合指标使用 1 年分析队列和 98%可信区间(CrI)来对表现优于预期(3 星级)或差于预期(1 星级)的情况进行分类。由于每个 STS 参与者的 CABG 量(例如,医院或实践组)减少,使用这种方法进行绩效分类变得更加具有挑战性,尤其是对于低容量计划而言,因此已经探索了替代方法。
在 990 名 STS 成人心脏手术数据库参与者中,使用各种分析队列研究了 CABG 综合指标的绩效分类:1 年(当前方法,2017 年);3 年(2015 年至 2017 年);过去 3 年内的最后 450 例病例;以及最近一年(2017 年)加 450 例总例数。我们还将 98%CrI 与 95%CrI(用于其他 STS 综合指标)进行了比较。
使用 3 年的数据和 95%CrI,990 名参与者中有 113 名(11.4%)被分类为 1 星级,198 名(20%)为 3 星级。与 1 年分析队列和 98%CrI 相比,3 星级参与者的绝对和相对比例增加了 14 个百分点和 233%(n=198 [20%] 比 n=59 [6%])。1 星级参与者的相应变化为 6.5 个百分点和 133%(n=113 [11.4%] 比 n=48 [4.9%])。这些变化在较低容量(每年少于 199 例 CABG)的参与者中更为明显。使用 3 年、95%CrI 修正的测量可靠性为 0.78。
与当前 STS CABG 综合方法相比,3 年分析队列和 95%CrI 增加了表现优于或差于预期的异常值的数量和比例,尤其是在低容量成人心脏手术数据库参与者中。这种修订后的方法现在也与其他 STS 手术综合指标一致。